Logo image of DAP.DE

DANAHER CORP (DAP.DE) Stock Fundamental Analysis

FRA:DAP - Deutsche Boerse Ag - US2358511028 - Common Stock - Currency: EUR

178.02  +2.28 (+1.3%)

Fundamental Rating

5

Taking everything into account, DAP scores 5 out of 10 in our fundamental rating. DAP was compared to 22 industry peers in the Life Sciences Tools & Services industry. DAP has an excellent profitability rating, but there are some minor concerns on its financial health. DAP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year DAP was profitable.
DAP had a positive operating cash flow in the past year.
DAP had positive earnings in each of the past 5 years.
Each year in the past 5 years DAP had a positive operating cash flow.
DAP.DE Yearly Net Income VS EBIT VS OCF VS FCFDAP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1.2 Ratios

The Return On Assets of DAP (4.18%) is better than 72.73% of its industry peers.
With a decent Return On Equity value of 6.52%, DAP is doing good in the industry, outperforming 63.64% of the companies in the same industry.
DAP has a Return On Invested Capital (5.32%) which is comparable to the rest of the industry.
DAP had an Average Return On Invested Capital over the past 3 years of 6.76%. This is significantly below the industry average of 12.40%.
Industry RankSector Rank
ROA 4.18%
ROE 6.52%
ROIC 5.32%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
DAP.DE Yearly ROA, ROE, ROICDAP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

DAP has a better Profit Margin (14.21%) than 77.27% of its industry peers.
In the last couple of years the Profit Margin of DAP has remained more or less at the same level.
DAP's Operating Margin of 19.79% is amongst the best of the industry. DAP outperforms 86.36% of its industry peers.
In the last couple of years the Operating Margin of DAP has grown nicely.
DAP has a Gross Margin of 59.72%. This is amongst the best in the industry. DAP outperforms 86.36% of its industry peers.
In the last couple of years the Gross Margin of DAP has remained more or less at the same level.
Industry RankSector Rank
OM 19.79%
PM (TTM) 14.21%
GM 59.72%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
DAP.DE Yearly Profit, Operating, Gross MarginsDAP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

DAP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for DAP has been reduced compared to 1 year ago.
DAP has more shares outstanding than it did 5 years ago.
DAP has a better debt/assets ratio than last year.
DAP.DE Yearly Shares OutstandingDAP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
DAP.DE Yearly Total Debt VS Total AssetsDAP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

DAP has an Altman-Z score of 4.33. This indicates that DAP is financially healthy and has little risk of bankruptcy at the moment.
DAP has a Altman-Z score of 4.33. This is amongst the best in the industry. DAP outperforms 86.36% of its industry peers.
The Debt to FCF ratio of DAP is 3.57, which is a good value as it means it would take DAP, 3.57 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.57, DAP is doing good in the industry, outperforming 77.27% of the companies in the same industry.
A Debt/Equity ratio of 0.32 indicates that DAP is not too dependend on debt financing.
DAP has a Debt to Equity ratio of 0.32. This is in the better half of the industry: DAP outperforms 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.57
Altman-Z 4.33
ROIC/WACC0.52
WACC10.22%
DAP.DE Yearly LT Debt VS Equity VS FCFDAP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

A Current Ratio of 1.62 indicates that DAP should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.62, DAP is in line with its industry, outperforming 54.55% of the companies in the same industry.
DAP has a Quick Ratio of 1.22. This is a normal value and indicates that DAP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DAP (1.22) is better than 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.22
DAP.DE Yearly Current Assets VS Current LiabilitesDAP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

DAP shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.84%.
Measured over the past years, DAP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.77% on average per year.
DAP shows a small growth in Revenue. In the last year, the Revenue has grown by 1.89%.
DAP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.92% yearly.
EPS 1Y (TTM)-2.84%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%4.65%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%3.36%

3.2 Future

Based on estimates for the next years, DAP will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.96% on average per year.
The Revenue is expected to grow by 5.96% on average over the next years.
EPS Next Y3.94%
EPS Next 2Y7.54%
EPS Next 3Y8.61%
EPS Next 5Y8.96%
Revenue Next Year3.01%
Revenue Next 2Y4.72%
Revenue Next 3Y5.61%
Revenue Next 5Y5.96%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DAP.DE Yearly Revenue VS EstimatesDAP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
DAP.DE Yearly EPS VS EstimatesDAP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.56, DAP can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as DAP.
The average S&P500 Price/Earnings ratio is at 27.91. DAP is around the same levels.
Based on the Price/Forward Earnings ratio of 23.95, the valuation of DAP can be described as rather expensive.
DAP's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.11, DAP is valued a bit cheaper.
Industry RankSector Rank
PE 27.56
Fwd PE 23.95
DAP.DE Price Earnings VS Forward Price EarningsDAP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

DAP's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DAP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 30.54
EV/EBITDA 22.54
DAP.DE Per share dataDAP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of DAP may justify a higher PE ratio.
PEG (NY)6.99
PEG (5Y)2.82
EPS Next 2Y7.54%
EPS Next 3Y8.61%

5

5. Dividend

5.1 Amount

DAP has a yearly dividend return of 0.63%, which is pretty low.
DAP's Dividend Yield is a higher than the industry average which is at 0.69.
Compared to an average S&P500 Dividend Yield of 2.32, DAP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.63%

5.2 History

The dividend of DAP is nicely growing with an annual growth rate of 6.91%!
Dividend Growth(5Y)6.91%
Div Incr Years5
Div Non Decr Years5
DAP.DE Yearly Dividends per shareDAP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

23.85% of the earnings are spent on dividend by DAP. This is a low number and sustainable payout ratio.
DAP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP23.85%
EPS Next 2Y7.54%
EPS Next 3Y8.61%
DAP.DE Yearly Income VS Free CF VS DividendDAP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
DAP.DE Dividend Payout.DAP.DE Dividend Payout, showing the Payout Ratio.DAP.DE Dividend Payout.PayoutRetained Earnings

DANAHER CORP

FRA:DAP (7/29/2025, 7:00:00 PM)

178.02

+2.28 (+1.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-20 2025-10-20/amc
Inst Owners82.15%
Inst Owner ChangeN/A
Ins Owners10.83%
Ins Owner ChangeN/A
Market Cap127.40B
Analysts85.16
Price Target218.45 (22.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.63%
Yearly Dividend0.9
Dividend Growth(5Y)6.91%
DP23.85%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.86%
Min EPS beat(2)8.42%
Max EPS beat(2)13.3%
EPS beat(4)3
Avg EPS beat(4)6.93%
Min EPS beat(4)-1.93%
Max EPS beat(4)13.3%
EPS beat(8)7
Avg EPS beat(8)7.86%
EPS beat(12)11
Avg EPS beat(12)7.64%
EPS beat(16)15
Avg EPS beat(16)7.84%
Revenue beat(2)2
Avg Revenue beat(2)1.19%
Min Revenue beat(2)0.68%
Max Revenue beat(2)1.7%
Revenue beat(4)4
Avg Revenue beat(4)1.45%
Min Revenue beat(4)0.66%
Max Revenue beat(4)2.75%
Revenue beat(8)8
Avg Revenue beat(8)1.98%
Revenue beat(12)9
Avg Revenue beat(12)-4.19%
Revenue beat(16)12
Avg Revenue beat(16)-6.15%
PT rev (1m)0.49%
PT rev (3m)-1.8%
EPS NQ rev (1m)-4.26%
EPS NQ rev (3m)-7.84%
EPS NY rev (1m)0.1%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)0.81%
Revenue NQ rev (3m)1.68%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 27.56
Fwd PE 23.95
P/S 6.18
P/FCF 30.54
P/OCF 24.07
P/B 2.84
P/tB N/A
EV/EBITDA 22.54
EPS(TTM)6.46
EY3.63%
EPS(NY)7.43
Fwd EY4.18%
FCF(TTM)5.83
FCFY3.27%
OCF(TTM)7.4
OCFY4.15%
SpS28.79
BVpS62.75
TBVpS-11.13
PEG (NY)6.99
PEG (5Y)2.82
Profitability
Industry RankSector Rank
ROA 4.18%
ROE 6.52%
ROCE 6.35%
ROIC 5.32%
ROICexc 5.54%
ROICexgc 38.86%
OM 19.79%
PM (TTM) 14.21%
GM 59.72%
FCFM 20.25%
ROA(3y)6.35%
ROA(5y)6.24%
ROE(3y)10.31%
ROE(5y)10.73%
ROIC(3y)6.76%
ROIC(5y)6.52%
ROICexc(3y)7.22%
ROICexc(5y)6.94%
ROICexgc(3y)54.83%
ROICexgc(5y)57.37%
ROCE(3y)8.07%
ROCE(5y)7.78%
ROICexcg growth 3Y-10.53%
ROICexcg growth 5Y-4.54%
ROICexc growth 3Y-4.88%
ROICexc growth 5Y-2.88%
OM growth 3Y-5.38%
OM growth 5Y3.63%
PM growth 3Y-13.55%
PM growth 5Y-0.1%
GM growth 3Y-1.01%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 3.57
Debt/EBITDA 2.36
Cap/Depr 54.73%
Cap/Sales 5.44%
Interest Coverage 13.86
Cash Conversion 86.39%
Profit Quality 142.46%
Current Ratio 1.62
Quick Ratio 1.22
Altman-Z 4.33
F-Score7
WACC10.22%
ROIC/WACC0.52
Cap/Depr(3y)58.29%
Cap/Depr(5y)55.83%
Cap/Sales(3y)5.31%
Cap/Sales(5y)4.94%
Profit Quality(3y)120.48%
Profit Quality(5y)125.69%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.84%
EPS 3Y-9.37%
EPS 5Y9.77%
EPS Q2Q%4.65%
EPS Next Y3.94%
EPS Next 2Y7.54%
EPS Next 3Y8.61%
EPS Next 5Y8.96%
Revenue 1Y (TTM)1.89%
Revenue growth 3Y-1.26%
Revenue growth 5Y5.92%
Sales Q2Q%3.36%
Revenue Next Year3.01%
Revenue Next 2Y4.72%
Revenue Next 3Y5.61%
Revenue Next 5Y5.96%
EBIT growth 1Y-6.03%
EBIT growth 3Y-6.57%
EBIT growth 5Y9.77%
EBIT Next Year11.73%
EBIT Next 3Y9.92%
EBIT Next 5Y10.23%
FCF growth 1Y-32.49%
FCF growth 3Y-9.16%
FCF growth 5Y9.82%
OCF growth 1Y-26.77%
OCF growth 3Y-7.16%
OCF growth 5Y11.1%